Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica L F Teh

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Pigment Cell & Melanoma Research|May 26, 2016
Frizzled with age: an opportunity for 'gerontological medicine'Jessica L F Teh
Pigment Cell & Melanoma Research|January 26, 2012
Glutamatergic signaling in cellular transformationJessica L F Teh, Suzie Chen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Playing the Melanoma EndgameJessica L F Teh, Andrew E Aplin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2018
Arrested Developments: CDK4/6 Inhibitor Resistance and Alterations in the Tumor Immune MicroenvironmentJessica L F Teh, Andrew E Aplin
Pigment Cell & Melanoma Research|March 18, 2014
Metabotropic glutamate receptor 1 mediates melanocyte transformation via transactivation of insulin-like growth factor 1 receptorJessica L F Teh, Raj Shah, Seung-Shick Shin, et al.
Cancer Research|August 5, 2016
An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in MelanomaJessica L F Teh, Timothy J Purwin, Evan J Greenawalt, et al.
The Journal of Investigative Dermatology|May 12, 2020
Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase InhibitionMai Q Nguyen, Jessica L F Teh, Timothy J Purwin, et al.
Cancer Immunology Research|July 15, 2020
Activation of CD8<sup>+</sup> T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK InhibitorsJessica L F Teh, Dan A Erkes, Phil F Cheng, et al.
Molecular Cancer Therapeutics|May 21, 2020
Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal MelanomaJessica L F Teh, Timothy J Purwin, Anna Han, et al.
Breast Cancer Research and Treatment|April 11, 2015
Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cellsJessica L F Teh, Raj Shah, Stephanie La Cava, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Pigment Cell & Melanoma Research|May 26, 2016
Frizzled with age: an opportunity for 'gerontological medicine'Jessica L F Teh
Pigment Cell & Melanoma Research|January 26, 2012
Glutamatergic signaling in cellular transformationJessica L F Teh, Suzie Chen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Playing the Melanoma EndgameJessica L F Teh, Andrew E Aplin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2018
Arrested Developments: CDK4/6 Inhibitor Resistance and Alterations in the Tumor Immune MicroenvironmentJessica L F Teh, Andrew E Aplin
Pigment Cell & Melanoma Research|March 18, 2014
Metabotropic glutamate receptor 1 mediates melanocyte transformation via transactivation of insulin-like growth factor 1 receptorJessica L F Teh, Raj Shah, Seung-Shick Shin, et al.
Cancer Research|August 5, 2016
An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in MelanomaJessica L F Teh, Timothy J Purwin, Evan J Greenawalt, et al.
The Journal of Investigative Dermatology|May 12, 2020
Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase InhibitionMai Q Nguyen, Jessica L F Teh, Timothy J Purwin, et al.
Cancer Immunology Research|July 15, 2020
Activation of CD8<sup>+</sup> T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK InhibitorsJessica L F Teh, Dan A Erkes, Phil F Cheng, et al.
Molecular Cancer Therapeutics|May 21, 2020
Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal MelanomaJessica L F Teh, Timothy J Purwin, Anna Han, et al.
Breast Cancer Research and Treatment|April 11, 2015
Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cellsJessica L F Teh, Raj Shah, Stephanie La Cava, et al.
Pageof 2